ViroGates Valuation
ViroGates seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of ViroGates AS from inspecting the company fundamentals such as Return On Equity of -0.62, shares outstanding of 3.35 M, and Operating Margin of (1.27) % as well as reviewing its technical indicators and probability of bankruptcy.
ViroGates Total Value Analysis
ViroGates AS is at this time estimated to have takeover price of 122.74 M with market capitalization of 191.08 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ViroGates fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
122.74 M | 191.08 M |
ViroGates Investor Information
About 50.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 5.16. ViroGates AS had not issued any dividends in recent years. Based on the key indicators related to ViroGates' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, ViroGates AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.ViroGates Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ViroGates has an asset utilization ratio of 37.85 percent. This suggests that the Company is making USD0.38 for each dollar of assets. An increasing asset utilization means that ViroGates AS is more efficient with each dollar of assets it utilizes for everyday operations.ViroGates Ownership Allocation
The market capitalization of ViroGates is USD191.08 Million. ViroGates AS maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.ViroGates Profitability Analysis
The company reported the revenue of 7.66 M. Net Loss for the year was (17.66 M) with profit before overhead, payroll, taxes, and interest of 5.79 M.About ViroGates Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of ViroGates AS. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ViroGates AS based exclusively on its fundamental and basic technical indicators. By analyzing ViroGates's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of ViroGates's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of ViroGates. We calculate exposure to ViroGates's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ViroGates's related companies.8 Steps to conduct ViroGates' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ViroGates' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ViroGates' valuation analysis, follow these 8 steps:- Gather financial information: Obtain ViroGates' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ViroGates' revenue streams: Identify ViroGates' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ViroGates' industry and market trends, including the size of the market, growth rate, and competition.
- Establish ViroGates' growth potential: Evaluate ViroGates' management, business model, and growth potential.
- Determine ViroGates' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ViroGates' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in ViroGates Stock
ViroGates financial ratios help investors to determine whether ViroGates Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ViroGates with respect to the benefits of owning ViroGates security.